OCT 07, 2017 1:49 PM PDT

Defective Viral Genomes Help Infections Linger

WRITTEN BY: Kara Marker

Cells that are infected with a virus sacrifice themselves, dying before the virus has a chance to use the cell’s own machinery to replicate and spread to other cells. This is why viral infections like respiratory syncytial virus (RSV), measles, parainfluenza, and Ebola are acute, not long-lasting. But when viruses find a way to linger in their host’s cells without being killed by the immune system, the infection transforms from acute to chronic, causing multiple complications.

Making insights into how virus-infected cells can survive the onslaught of an immune response, researchers have found that cells enriched with defective viral genomes (in green) had strategies to persist, unlike cells with more full-length viral genomes (in orange/yellow). Credit: University of Pennsylvania

In a new Nature Communications study, researchers from the University of Pennsylvania identify a mechanism responsible for viruses overstaying their welcome in the human body. The culprit? Defective viral genomes.

As a virus invades the body and begins to mass-produce itself by manipulating the replication machinery of the body’s own cells, the virus can make mistakes while replicating the genome, leading to defective viral genomes (DVGs) present in some cells. Senior author of the new study, Carolina B. López, has researched DVGs for a long time. Interestingly, DVGs simultaneously instigate an immune response to the virus and stimulate a molecular pathway that prevents infected cells from self destruction.

“DVGs promote persistent infections in tissue culture," López explained. "How do you reconcile that with the fact that they're also very immunostimulatory? How can they help clear virus at the same time as they promote persistence? Our work helps explain this apparent paradox."

In her newest study, López and her team of researchers observed DVGs in cells, picking apart the cells with full-length genomes, the cells with DVGs, and the cells with some of each. Then, researchers infected healthy cells with either RSV or the Sendai virus, looking at the difference when viruses were DVG-deficient versus DVG-rich.

In their study, researchers used Respiratory Syncytial Virus (pictured) and the Sendai virus, also known as murine parainfluenza virus type 1, is an RNA virus not pathogenic to humans. It was first isolated in the 1950s in Japan and has been used ever since as a tool in the research lab.

Researchers observed cells infected with DVG-rich virus surviving significantly longer than those with DVG-deficient viruses, confirming that DVGs were directly involved in the survival of virally-infected cells.

How exactly are DVG-rich virally-infected cells avoiding apoptosis? A gene expression analysis revealed that “pro-survival genes” are very active in DVG-rich cells.

“These data show that our cells are wired to survive if they are engaged in an antiviral response, explaining the paradoxical functions of DVGs,” Lopez explained. “It seems that in order to persist, the virus is taking advantage of these host pathways that are there to promote the survival of cells working to eliminate the virus."

Now that Lopez knows how viruses are able to linger in the body, she hopes to find a way to prevent this from happening. "I want to see if there's a way we can harness this pathway to minimize and avoid the persistence of these viruses.”

Sources: Current Gene Therapy, University of Pennsylvania

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 07, 2021
Immunology
A 3D-Printed COVID Vaccine Patch?
OCT 07, 2021
A 3D-Printed COVID Vaccine Patch?
Even the bravest souls can get a little nervous when it comes to rolling up their sleeves and getting a shot. Aichmophob ...
OCT 14, 2021
Immunology
'Bio-Betters' Form the Next Wave of Cancer Therapies
OCT 14, 2021
'Bio-Betters' Form the Next Wave of Cancer Therapies
  Antibodies are blood proteins with highly specialized functions: to recognize and eliminate bacteria, viruses, an ...
OCT 21, 2021
Immunology
Sunshine Vitamin Boosts Dairy Cows' Immunity
OCT 21, 2021
Sunshine Vitamin Boosts Dairy Cows' Immunity
A new study shows how vitamin D can help dairy cows fend off infections, offering opportunities for better animal health ...
NOV 05, 2021
Cancer
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
NOV 05, 2021
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
Every year, Labroots hosts an exciting series of Virtual Events that focus on various scientific topics. These virtual m ...
NOV 11, 2021
Cell & Molecular Biology
Why Arthritis Tends to Affect the Same Joints Repeatedly
NOV 11, 2021
Why Arthritis Tends to Affect the Same Joints Repeatedly
While arthritis may not cause pain all the time, when it flares, it tends to recur in the same joints. This can create s ...
JAN 13, 2022
Cancer
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
JAN 13, 2022
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
The American Cancer Society estimates the lifetime risk of pancreatic cancer at about 1 in 64. Pancreatic duct ...
Loading Comments...